Literature DB >> 16523192

Polymorphisms in the gene encoding hepatocyte nuclear factor-4alpha and susceptibility to type 2 diabetes in a Polish population.

K Wanic1, M T Malecki, P P Wolkow, T Klupa, J Skupien, J Bobrek, E Kozek, A S Krolewski, J Sieradzki.   

Abstract

Recently, several association studies of type 2 diabetes mellitus (T2DM) and the hepatocyte nuclear factor (HNF)-4alpha gene were reported with conflicting results. Our aim was to search for association between two polymorphisms of HNF-4alpha and T2DM in Polish Caucasians. The study groups comprised of 461 T2DM cases and 366 controls. Genotype-quantitative trait analyses were based on the oral glucose tolerance test (OGTT), glucose and insulin results, and comprised 310 glucose-tolerant subjects. All individuals were genotyped for two HNF-4alpha polymorphisms. The frequencies of the minor alleles were as follows: 19.2% in T2DM vs. 17.6% in controls for rs2144908; and 20.6% vs. 20.1% for rs4810424, respectively. The distributions of alleles, genotypes, and haplotypes of the HNF-4alpha polymorphisms did not differ between the study groups (lowest P = 0.41). None of the examined SNPs showed an association in control subjects with quantitative traits of fasting plasma glucose, fasting insulin, as well as plasma glucose and insulin 2 hours after glucose load in OGTT. We conclude that both examined polymorphisms in HNF-4alpha are not associated with T2DM and prediabetic phenotypes in Polish Caucasian study groups of this size.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16523192     DOI: 10.1016/s1262-3636(07)70252-5

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  4 in total

Review 1.  Acute lung injury and the coagulation pathway: Potential role of gene polymorphisms in the protein C and fibrinolytic pathways.

Authors:  Anil Sapru; Joseph L Wiemels; John S Witte; Lorraine B Ware; Michael A Matthay
Journal:  Intensive Care Med       Date:  2006-06-13       Impact factor: 17.440

2.  Analysis of candidate genes on chromosome 20q12-13.1 reveals evidence for BMI mediated association of PREX1 with type 2 diabetes in European Americans.

Authors:  Joshua P Lewis; Nicholette D Palmer; Jennifer B Ellington; Jasmin Divers; Maggie C Y Ng; Lingyi Lu; Carl D Langefeld; Barry I Freedman; Donald W Bowden
Journal:  Genomics       Date:  2010-07-30       Impact factor: 5.736

3.  Hepatocyte nuclear factor 4 alpha polymorphisms and the metabolic syndrome in French-Canadian youth.

Authors:  Valérie Marcil; Devendra Amre; Ernest G Seidman; François Boudreau; Fernand P Gendron; Daniel Ménard; Jean François Beaulieu; Daniel Sinnett; Marie Lambert; Emile Levy
Journal:  PLoS One       Date:  2015-02-11       Impact factor: 3.240

4.  Population-specific risk of type 2 diabetes conferred by HNF4A P2 promoter variants: a lesson for replication studies.

Authors:  Inês Barroso; Jian'an Luan; Eleanor Wheeler; Pamela Whittaker; Jon Wasson; Eleftheria Zeggini; Michael N Weedon; Sarah Hunt; Ranganath Venkatesh; Timothy M Frayling; Marcos Delgado; Rosalind J Neuman; Jinghua Zhao; Richard Sherva; Benjamin Glaser; Mark Walker; Graham Hitman; Mark I McCarthy; Andrew T Hattersley; M Alan Permutt; Nicholas J Wareham; Panagiotis Deloukas
Journal:  Diabetes       Date:  2008-08-26       Impact factor: 9.461

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.